Member Info for MrMilton

Totally undervalued. SP at least 30P

Yes I think so. Don't know why this one is down so much. I went through their all reports. But did not find any sold reason behind it. Yes-off course, sales down, last quarter in loss, £13 million loam. But looking at their overall asset. This cap should be at least over £20-£25 Million. which gives the share price at least 30p!!! Totally undervalued.

tomorrow is a big day , can be heading towards 15-16 P

lot of big buying pressure .Even 14-16 p Possible end of today

My first Target is 20P , then 25 to 30P

I got a feel that the next update will not only be about their progress on the trials, but also will be able to have some news on commercialisation, that's why Nigel it taking long time for the update. We need to keep patience and this will boom with the positive news.

News is on the way- Expecting some exciting time ahead with Good update will take this share price to 20 to 25P

https://www.irishpost.com/news/anti-covid-pill-could-replace-jabs-as-green-light-is-given-for-clinical-trials-to-begin-201514

N4p is also doing research about oral vaccine. You never know , if successful this will be multi bug. Just like INM bio which was only $5-$6 range & now it is over $24. All we need is patient. Let’s see what Nigel deliver this time - lot of things to come - Vaccine delivery system , oral vaccine proof of concept update , update on commercial news.
Any positive news will make the SP moving faster with a short time target to 25p.

With the big buy give confidence that - what people expect from it. hugely potential from on. MM was trying to mark it down since morning to fill up this huge buy at 8.30P - 1.2 million share. Apart from some people ( who was trying to de ramp it ) we all know what N4p technology worth - we just need phase 3 trial goes well and laster on commercial news. This one can be next NCYT --with huge potential. Expecting some news by Friday or next week. Tomorrow will be another interesting day- can easily go over 9.50p in the morning.

Start reading RNS from Oct to till now- then you will find out. Including the recent DEC RNS....

Recent few RNS mentioned about the timeline about the update. with the news about to come -it is time to sit down and wait for the party. According to last few RNS - news is due soon.

You are absolutely right. With the Nuvec it could reach even 20P and with good collaboration easily 40P possible.

very much confident about his last few RNS- with the success of the trial - commercialisation is on the card, last placing was seriously over subscribed. So all positive news and last placing was not that bad at 8P. First good news will be the trial result, next to come with the commercialisation this will boost up the share price. Current COVID condition is favourable to N4P and with the good news price can easily move up quickly and depending on the price who know it can gain 200-300% increase in value.

I am expecting 10-11P with out news. Depending on the news it could go up to 20p

10p on the card. Expecting 10p before the news & with the final update coming it will move towards my target 20p.

It is the right time to invest here now. Then sit down and see the next rise. According to the last RNS - The placing was significantly over subscribed ( which confirmed it's demand in the market) and also commercialisation is no the card ( if trial goes well).

The important part of the RNS : Whilst we are well funded for all existing work streams these additional funds will enable us to plan for follow on studies and more product focussed experiments as we move towards collaboration.
With the funding they have now will be useful for them to go straight to Collaboration. It’s time to invest here & sit down for the play.

More than 2.5 million buy and already 18% up. The currency report already mentioned the positive sense there with the reduced their liability ( which is relatively not liability).

RBS out : Profitibily for the 1st 6 months .
Net asset value is nearly 22 million which suggests around 3.9 p per share which is well well over existing price.
Should get a proper re rating over 3 p soon

Yes- COVID passport is the only option to track it and one deal is done- CTEA will be more deal to come. Expecting some exciting time from now on.